Integrated Diagnostics Holdings plc (FRA:8I8)

Market Cap	308.69M +54.4%
Revenue (ttm)	140.26M +37.3%
Net Income	22.54M +17.1%
EPS	0.04 +19.6%
Shares Out	n/a
PE Ratio	13.70
Forward PE	n/a
Dividend	0.01 (3.02%)
Ex-Dividend Date	Sep 11, 2025

Volume	n/a
Average Volume	44
Open	0.4920
Previous Close	0.4900
Day's Range	0.4920 - 0.4920
52-Week Range	0.2320 - 0.7100
Beta	n/a
RSI	50.99
Earnings Date	Sep 2, 2026

About FRA:8I8

Integrated Diagnostics Holdings plc operates as a consumer healthcare company that provides medical diagnostics services to patients. It offers approximately 3,000 diagnostic pathology tests, such as immunology, microbiology, haematology, endocrinology, clinical chemistry, molecular biology, parasitology, histopathology, and genetics. The company also provides radiology services, such as positron emission tomography - computed tomography (PET-CT), MRI, computed tomography (CT), mammography, ultrasound, X-Ray, electromyography, electroencephalog...

• Industry: Medical Laboratories
• Founded: 1979
• Employees: 6,309
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 8I8

Financial Performance

In 2025, FRA:8I8's revenue was 7.86 billion, an increase of 37.34% compared to the previous year's 5.72 billion. Earnings were 1.26 billion, an increase of 17.15%.

Financial numbers in EGP